Immunodiagnostic Systems Holdings plc has published its Annual Report & Accounts for the year ended 31 March 2013. Visit Financial Reports
Immunodiagnostic Systems Holdings plc has published its Annual Report & Accounts for the year ended 31 March 2013. Visit Financial Reports
IDS (“IDS” or ‘”the Company”) is pleased to announce that it has received USA FDA (Food and Drug Administration) clearance for its 1,25-Dihyroxy Vitamin D assay for use on the IDS-iSYS system.
Immunodiagnostic Systems Holdings PLC Final Results for the year ended 31 March 2013